Loading resource…

American College of Cardiology Foundation
Heart failure with improved ejection fraction (HFimpEF) is increasingly recognized as a distinct phenotype characterized by previously reduced left ventricular ejection fraction that improves to above 40%. Despite recovery, patients with HFimpEF remain at risk for adverse outcomes, and their management is an area of active investigation. This review highlights existing clinical gaps and proposes future research directions to refine risk stratification and therapeutic approaches for this evolving population.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology

PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology

OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology

CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology

The Athlete’s ECG
Same clinical topic · Cardiology

Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology

Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology

Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology

INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology